Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten

Happy Friday!
News
16285-a-female-doctor-examining-an-elderly-male-patient-pv

Current drugs are “poisoning” elderly patients due to insufficient trial data, House of Lords committee hears

November 1, 2019 Medical Communications, Research and Development elderly patients, pharma, trial diversity

Elderly patients are being put at risk by prescriptions for drugs which have not been properly tested in their age …
News
shutterstock_192094955_web

England’s antibiotic use is down, but antibiotic-resistant infections still spreading, report warns

November 1, 2019 Medical Communications, Research and Development Antibiotics, England, Review on antimicrobial resistance

A new report has revealed that GPs in England are writing fewer prescriptions for antibiotics, but this has done little …
News
shutterstock_87495637

Amgen drops $2.7bn to acquire stake in Chinese biotech in bid to expand in the region

November 1, 2019 Medical Communications, Research and Development, Sales and Marketing Amgen, BeiGene, Cancer, China, deal, oncology, pharma

Amgen has signed an agreement with Chinese biotech BeiGene to acquire a 20.5% stake in the latter, in a bid …
News

Despite some advantages, Novartis’ Cosentyx fails to outclass Humira in active psoriatic arthritis

November 1, 2019 Medical Communications, Research and Development Cosentyx, Humira, Novartis, active psoriatic arthritis, pharma

Novartis has announced new data drawn from a trial pitting Cosentyx (secukinumab) in head-to-head competition with AbbVie’s Humira (adalimumab) – …
News
shutterstock_273326141

Transactions in the pharma sector: Through the EU merger review looking-glass

October 31, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mergers, mergers and acquisitions, pharma

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) …
Feature
abbvie_0

AbbVie’s Rinvoq impresses at Phase 3 in active psoriatic arthritis sub-population

October 31, 2019 Research and Development AbbVie, Rinvoq, pharma

AbbVie has unveiled new Phase 3 data on two doses of its JAK inhibitor Rinvoq (upadacitinib), showing that the therapy …
News
index

Catalyst’s lead candidate Firdapse falls short in Congenital Myasthenic Syndromes

October 31, 2019 Research and Development Catalyst Pharmaceuticals, FDA, firdapse, pharma, trial failure

Catalyst Pharmaceuticals has made it known that its lead product Firdapse (Amifampridine Phosphate) fell short of its primary endpoint in …
News
shutterstock_212432119

Morphosys, Novartis and Galaagos shut down development of atopic dermatitis candidate

October 31, 2019 Research and Development Galapagos, Novartis, atopic dermatitis, morphosys, pharma

The trio of Galapagos, MorphoSys and Novartis Pharma has revealed that all further development of its MOR106 drug candidate for …
News
david_eatwell

Genmab’s Executive VP and CFO to retire in 2020

October 31, 2019 Research and Development Genmab, appointment, pharma

David Eatwell, Executive Vice President and Chief Financial Officer at Genmab, has announced his intention to step down from the …
News
pharmafocus_november_2019_front_cover

The November 2019 issue of Pharmafocus is available to read for free online now!

October 30, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The latest monthly edition of Pharmafocus, the November issue, is available to read for free online now!
News

FDA approves Biogen and Alkermes’ Vumerity for relapsing multiple sclerosis

October 30, 2019 Research and Development, Sales and Marketing Alkermes, Biogen, FDA, Vumerity, multiple sclerosis, pharma

The FDA has given the green light to Vumerity (diroximel fumarate), a novel oral fumarate developed by Biogen and Alkermes, …
News

FDA slams brakes on trial for world’s most expensive drug following safety concerns in children

October 30, 2019 Research and Development FDA, Novartis, Zolgensma, pharma

The FDA has temporarily shut down a clinical trial evaluating Zolgensma – the world’s most expensive drug at $3.1 million …
News

Expanded EU label for Benlyta now covers paediatric lupus patients

October 30, 2019 Research and Development, Sales and Marketing Benlyta, Europe, GSK, Lupus, pharma

GlaxoSmithKline is celebrating the news that the European Commission has chosen to approve an expansion to the label of its …
News

European Commission approves Sanofi’s Dupixent in chronic rhinosinusitis with nasal polyposis

October 30, 2019 Research and Development, Sales and Marketing Dupixent, EU, Sanofi, pharma

Sanofi’s Dupixent (dupilumab) has secured European approval for the treatment of chronic rhinosinusitis with nasal polyposis (CRSwNP), it has emerged. …
News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026